A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children
- 1 November 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 360 (9344) , 1468-1475
- https://doi.org/10.1016/s0140-6736(02)11474-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A Review of Polymorphisms in the Human Gene for Inducible Nitric Oxide Synthase (NOS2) in Patients with MalariaSepsis, 2001
- Nitric Oxide Synthase Type 2 Promoter Polymorphisms, Nitric Oxide Production, and Disease Severity in Tanzanian Children with MalariaThe Journal of Infectious Diseases, 1999
- Inducible nitric oxide synthase polymorphism and fatal cerebral malariaThe Lancet, 1998
- Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malariaThe Lancet, 1998
- Seroepidemiology of Rickettsia typhi, Spotted Fever Group Rickettsiae, and Coxiella burnetti Infection in Pregnant Women from Urban TanzaniaThe American Journal of Tropical Medicine and Hygiene, 1997
- Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in AfricaThe Lancet, 1997
- Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.The Journal of Experimental Medicine, 1996
- Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter.Proceedings of the National Academy of Sciences, 1996
- Indicators of Life-Threatening Malaria in African ChildrenNew England Journal of Medicine, 1995
- Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells.The Journal of Experimental Medicine, 1994